PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 3 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Crude extracts and the chloroform fraction exhibited significant cytotoxic and antiproliferative effects in vitro [PMID:31702502]. The novel ester 3-hydroxyoctyl -5- trans-docosenoate also showed cytotoxic effects against HepG-2 cell lines [PMID:31849451].
Green synthesized silver nanoparticles (AgNPs) from aqueous extract showed antibacterial activity against Enterobacter aerogens, Bordetella bronchiseptaca, and Salmonella typhimurium, and antifungal activity against Aspergillus fumagatus [PMID:39323117].
Evidence summary
PubMed sources
- 1.PMID: 31849451 (2019) — In Silico, Cytotoxic and Antioxidant Potential of Novel Ester, 3-hydroxyoctyl -5- trans-docosenoate Isolated from Anchusa arvensis (L.) M.Bieb. Against HepG-2 Cancer Cells. · Drug design, development and therapy
- 2.PMID: 31702502 (2019) — Cytotoxicity of Anchusa arvensis Against HepG-2 Cell Lines: Mechanistic and Computational Approaches. · Current topics in medicinal chemistry
- 3.PMID: 39323117 (2025) — Green synthesized AgNPs of the Anchusa arvensis aqueous extract resulting in impressive protein kinase, antioxidant, antibacterial, and antifungal activities. · Zeitschrift fur Naturforschung. C, Journal of biosciences